Harmony Biosciences Holdings

Healthcare · Biotechnology

39.60$ +0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Harmony Biosciences Holdings (HRMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 261 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HRMY
Line item	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	–	0.0	0.0	6.0	20	38	46	56	60	74	81	91	85	107	117	128	119	134	160	168	155	173	186	201	185	200	239	244	215	261	960
Cost of Revenue	–	0.0	0.0	1.6	3.5	6.5	7.9	9.9	10	13	15	18	15	19	23	27	21	25	32	43	27	32	43	54	32	38	60	69	45	63	236
Gross Profit	–	0.0	0.0	4.4	16	32	38	46	49	61	66	73	71	88	94	101	98	109	128	125	127	141	143	147	153	162	180	175	171	198	724
Research & Development	53	5.0	4.3	7.3	3.4	4.2	4.2	7.6	4.7	6.5	12	7.5	7.6	13	41	10	13	15	17	30	22	64	25	35	35	50	55	50	69	47	221
Selling, General & Administrative	4.0	5.9	13	14	9.3	7.6	11	13	15	14	17	18	18	22	21	23	22	23	23	28	26	27	29	29	31	34	30	58	33	28	148
Total Operating Expenses	63	19	30	38	26	24	27	39	35	38	45	45	43	55	82	54	58	62	63	85	75	119	82	91	96	114	114	137	134	109	493
Operating Income	-63	-19	-30	-34	-9.6	7.3	10	7.8	15	23	21	29	28	33	12	48	40	47	65	40	52	21	62	56	56	48	65	39	37	89	231
Interest Expense	–	1.4	2.1	2.7	6.4	6.9	6.9	8.0	7.1	7.2	5.5	4.3	4.2	4.2	4.9	3.6	5.7	6.2	7.0	4.8	4.5	4.4	4.3	4.2	3.8	3.6	3.6	3.5	3.2	3.1	13
Pre-Tax Income	-63	-21	-32	-36	-39	0.0	1.9	-0.2	7.4	16	-11	24	23	29	8.0	44	38	44	52	40	52	22	62	56	57	50	67	41	40	93	241
Income Tax Expense	–	–	–	–	29	6.9	5.4	-4.4	7.1	2.0	-0.9	1.8	1.9	5.7	-80	-4.4	8.3	9.8	13	13	13	10	16	6.7	12	9.9	17	18	7.2	18	60
Net Income	-63	-21	-32	-36	-39	0.0	1.9	-0.2	7.4	14	-9.6	23	21	24	88	49	29	34	38	27	38	12	46	49	46	40	51	22	32	75	181
EBITDA	-63	-19	-29	-32	-7.7	9.3	12	12	19	28	-0.4	7.3	33	39	18	54	50	56	65	61	62	32	72	66	67	59	73	52	49	102	276

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings